Benjamin Esque
Directeur Général chez Corstasis Therapeutics
Profil
Benjamin Esque is the founder of Corstasis Therapeutics.
Prior to founding Corstasis Therapeutics, he worked as a Director at NewBridge Global Ventures, Inc. from 2017 to 2018.
He also worked as a Manager-Sales at KOS Pharmaceuticals, Inc. Mr. Esque completed his undergraduate degree at the University of California.
Postes actifs de Benjamin Esque
| Sociétés | Poste | Début |
|---|---|---|
Corstasis Therapeutics
 Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Directeur Général | - |
Anciens postes connus de Benjamin Esque
| Sociétés | Poste | Fin |
|---|---|---|
| NEWBRIDGE GLOBAL VENTURES, INC. | Directeur/Membre du Conseil | 16/07/2018 |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Sales & Marketing | - |
Formation de Benjamin Esque
| University of California | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
NewBridge Global Ventures, Inc.
 NewBridge Global Ventures, Inc. Agricultural Commodities/MillingProcess Industries NewBridge Global Ventures, Inc. engages in the cultivation, manufacture, and distribution of medical and recreational cannabis. It also offers cannabis online education and consulting services. The company was founded by Ulrik Moll, Michael Maze, Mads H. Frederiksen and Morten Krarup in May 1983 and is headquartered in Alameda, CA. | Process Industries |
KOS Pharmaceuticals, Inc.
KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Health Technology |
Corstasis Therapeutics
Corstasis Therapeutics BiotechnologyHealth Technology Corstasis Therapeutics develops outpatient therapeutic options for patients suffering from fluid overload problems. The company is based in Henderson, NV. The company was founded by Benjamin Esque and he has been the CEO since incorporation. | Health Technology |
